Esomeprazole (Mitogut)
Esomeprazole
Dr Reddyæs Laboratories (Pty) Ltd
Registration
- Applicant
- Dr Reddyæs Laboratories (Pty) Ltd
- Certificate holder
- Dr Reddyõs Laboratories (Pty) Ltd
- Registrations
- 1
Variants
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Esomeprazole
- except when indicated for the temporary, short-term relief of heartburn and hyperacidity, subject to:
- a maximum daily dose of 20 milligrams
- a maximum treatment period of 14 days. (S2)
Consolidated Schedules 06 July 2026, lines 6239 to 6244
S2: Esomeprazole
- when indicated for the temporary, short-term relief of heartburn and hyperacidity subject to:
- a maximum daily dose of 20 milligrams
- a maximum treatment period of 14 days. (S4)
Consolidated Schedules 06 July 2026, lines 1921 to 1925
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
6-Methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
Drag to rotate. Structure from PubChem CID 9568614.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.